Automated pathology device moving forward in approval

A pathologist may welcome a new robotic co-worker soon. Clarapath Corporationa New York-based biotechnology company, has created a tool called Section To automate the pathology process. The device has not yet entered the market and is currently under review by the US Food and Drug Administration (FDA). Clarabeth Inc Star Division. Eric Feinstein, CEO of … Read more